Review
Open access
Aug 2026
Developing next-generation antibody-drug conjugates for breast cancer drug delivery: hurdles and advances in the clinic.
This review synthesizes literature spanning 1990-2026 on advances in ADC design and their clinical and translational implementation in breast cancer to support reframing antigen selection as a system-level challenge, supported by delivery-focused engineering, precision-medicine-driven trial design, and adaptive methodology.
Callum Chapman, A. Cheung, G. B. Armstrong et al.
· Expert Opinion on Drug Deliv... · 0 citations